Horizon Pharma (HZNP): Cutting PT Ahead of Earnings - Mizuho

October 31, 2016 6:26 AM EDT
Get Alerts HZNP Hot Sheet
Price: $16.80 --0%

Rating Summary:
    13 Buy, 2 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 19 | Down: 13 | New: 9
Trade HZNP Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Mizuho Securities analyst, Irina Koffler, reiterated her Buy rating on shares of Horizon Pharma (NASDAQ: HZNP) and cut her price target to $29 from $33 ahead of earnings.

The lower price target accounts for a more price sensitive environment and increased rebates. The analyst still views HZNP as fundamentally undervalued even with conservative assumptions, but advises caution in front of the FA data read-out in late December. No change to the Buy rating.

For an analyst ratings summary and ratings history on Horizon Pharma click here. For more ratings news on Horizon Pharma click here.

Shares of Horizon Pharma closed at $17.85 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Related Entities

Earnings, Irina Koffler

Add Your Comment